Portland’s former end-of-life care facility for residents diagnosed with HIV and AIDS has been recognized for its historic ...

HIV is spread by bodily fluids such as blood, breast milk or semen. It gradually weakens the body’s immune system and makes ...

The FDA has accepted Gilead Sciences’ new drug application for lenacapavir as a long-lasting injectable to prevent HIV ...

Portland's Juniper House has been added to the National Register of Historic Places, marking a significant recognition of its ...

The consequences of a U.S. retreat from the global response to HIV/AIDS would be immense, jeopardizing 40 years of progress.

If PEPFAR is not reauthorized for the next four years, and without other resources for the HIV response, there would be 6.3 ...

Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the world is not on track to meet the ...

More than 20 years ago, the U.S. became the leader in the worldwide fight against HIV/AIDS. The Bush administration ...

Gilead Sciences has won Food and Drug Administration priority review for its proposed lenacapavir twice-yearly shot to prevent HIV. Gilead on Tuesday said an FDA green light would make lenacapavir the ...

President Trump's executive action ordering a 90-day pause on foreign development aid threatens the program called the ...

Despite breakthroughs in HIV treatment and prevention worldwide, critical challenges such as stigma, unequal access and ...